bersacapavir | Interleukin Related interleukin-related.com

Product Name :
bersacapavir

Search keywords :
Bersacapavir

drugId :
null

Target Vo:
Capsid protein

Target Vo Short Name :
Capsid

Moa_Name:
Capsid protein inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Johnson & Johnson

Active Company_Name :
Fisher Biopharma Services

Active Indication_Name:
Hepatitis B

In Active Indication_Name:
Hepatitis, Chronic

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:
Phase 2 Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Labetuzumab govitecan medchemexpress
PARP Rabbit mAb In stock
EGFR Antibody (YA775): EGFR Antibody (YA775) is a non-conjugated and Mouse origined monoclonal antibody about 134 kDa, targeting to EGFR (6H11). It can be used for WB,ICC/IF,IP assays with tag free, in the background of Human, Monkey.

Author: Interleukin Related

Related Posts